BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23620784)

  • 21. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 22. 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism.
    Akbulut T; Regner KR; Roman RJ; Avner ED; Falck JR; Park F
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F662-70. PubMed ID: 19570883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.
    Martínez-Palacián A; Del Castillo G; Herrera B; Fernández M; Roncero C; Fabregat I; Sánchez A
    Cell Signal; 2012 Feb; 24(2):505-513. PubMed ID: 22001397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
    Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
    Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes.
    Kasper M; Schnidar H; Neill GW; Hanneder M; Klingler S; Blaas L; Schmid C; Hauser-Kronberger C; Regl G; Philpott MP; Aberger F
    Mol Cell Biol; 2006 Aug; 26(16):6283-98. PubMed ID: 16880536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK.
    Sambade MJ; Camp JT; Kimple RJ; Sartor CI; Shields JM
    Radiother Oncol; 2009 Dec; 93(3):639-44. PubMed ID: 19853943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16.
    Bai T; Liu F; Zou F; Zhao G; Jiang Y; Liu L; Shi J; Hao D; Zhang Q; Zheng T; Zhang Y; Liu M; Li S; Qi L; Liu JY
    Stem Cells Dev; 2017 Jan; 26(2):113-122. PubMed ID: 27702388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
    Tyagi A; Sharma Y; Agarwal C; Agarwal R
    Pharm Res; 2008 Sep; 25(9):2143-50. PubMed ID: 18253818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells.
    Xiao D; Qu X; Weber HC
    Cell Signal; 2003 Oct; 15(10):945-53. PubMed ID: 12873708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations.
    Lazzara MJ; Lane K; Chan R; Jasper PJ; Yaffe MB; Sorger PK; Jacks T; Neel BG; Lauffenburger DA
    Cancer Res; 2010 May; 70(9):3843-50. PubMed ID: 20406974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach.
    Lange F; Rateitschak K; Kossow C; Wolkenhauer O; Jaster R
    World J Gastroenterol; 2012 Nov; 18(43):6226-34. PubMed ID: 23180942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
    Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
    Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of transcription factors by location-specific EGF receptor signaling via a spatio-temporal interplay of ERK activation.
    Wu P; Wee P; Jiang J; Chen X; Wang Z
    PLoS One; 2012; 7(9):e41354. PubMed ID: 22984397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells.
    Stewart JR; O'Brian CA
    Mol Cancer Ther; 2005 May; 4(5):726-32. PubMed ID: 15897236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation.
    Zhou W; Ibe BO; Raj JU
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2773-81. PubMed ID: 17322418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.
    Sauer L; Gitenay D; Vo C; Baron VT
    Oncogene; 2010 May; 29(18):2628-37. PubMed ID: 20190820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activating stress-activated protein kinase-mediated cell death and inhibiting epidermal growth factor receptor signaling: a promising therapeutic strategy for prostate cancer.
    Kumar R; Srinivasan S; Pahari P; Rohr J; Damodaran C
    Mol Cancer Ther; 2010 Sep; 9(9):2488-96. PubMed ID: 20736346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7.
    Friday E; Oliver R; Welbourne T; Turturro F
    Cell Physiol Biochem; 2007; 20(6):751-62. PubMed ID: 17982257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
    Hassan S; Dobner PR; Carraway RE
    Regul Pept; 2004 Aug; 120(1-3):155-66. PubMed ID: 15177934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.